The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
NURTEC ODT (Pfizer Australia Pty Ltd)
Product name
NURTEC ODT
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
159 (175 working days)
Active ingredients
rimegepant sulfate
Registration type
NCE/NBE
Indication
NURTEC ODT is indicated for
- acute treatment of migraine with or without aura in adults;
- prophylactic treatment of episodic migraine in adults who have at least 4 migraine attacks per month.